Abstract:Cognitive remediation therapy (CRT) demonstrates potential in enhancing cognitive function in schizophrenia (SZ), though the identification of molecular biomarkers remains challenging. The Neuritin-1 gene (NRN1) emerges as a promising candidate gene due to its association with SZ, cognitive performance and response to neurotherapeutic treatments. We aimed to investigate whether NRN1 genetic variability and methylation changes following CRT are related to cognitive improvements. Twenty-five SZ patients were randomly assigned to CRT or treatment-as-usual (TAU) groups, with cognitive function and NRN1 methylation assessed pre- and post-intervention using the MATRICS Consensus Cognitive Battery and EpiTYPER. Besides, eleven NRN1 polymorphisms were genotyped. Methylation changes (Δm = post - pre) were analyzed via sparse Partial Least Square Discriminant Analysis (sPLS-DA) to identify latent components (LCs) distinguishing CRT from TAU. To further explore methylation patterns of these LCs, CpG units were grouped into two subsets, yielding Δm means for those with increased and decreased methylation. Cognitive changes (Δcog = post - pre) were used to identify CRT improvers (CRT-I, Δcog ≥ 1), and the association between methylation changes and cognitive improvements post-therapy was also tested. We identified two LCs that differentiated CRT from TAU with a classification error rate of 0.28. The main component, LC1, included 25 CpG units. The subsets of CpG units with increased and decreased post-therapy methylation differed significantly between the two treatment arms, suggesting that differences were not merely data-driven but reflected meaningful biological variation. Additionally, CpG units linked to therapy were also associated with cognitive improvement, with LC1 and the subset of CpG units showing increased methylation post-therapy distinguishing CRT-I from the rest of the patients across multiple cognitive domains. Furthermore, the effect of LC1 on speed processing improvement after CRT was enhanced by considering the NRN1-rs9405890 polymorphism. Notably, these CpG units, particularly those with increased methylation after CRT, overlapped with key gene regulatory elements. Our model, integrating genetics and epigenetics, boosts the understanding of CRT response variability and highlights this multi-level approach as a promising strategy for identifying potential NRN1-related biomarkers of CRT effects, though further studies with larger samples are needed.

NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia

CLOZAPINE-RELATED BRAIN NRN1 EXPRESSION PATTERNS ARE ASSOCIATED WITH METHYLATION AND GENETIC VARIANTS IN SCHIZOPHRENIA

The C(−1562)T Polymorphism of Matrix Metalloproteinase-9 Gene is Associated with Schizophrenia in China

BDNF Gene's Role in Schizophrenia: From Risk Allele to Methylation Implications

Association of BDNF Gene Polymorphisms with Schizophrenia and Clinical Symptoms in a Chinese Population

Genetic polymorphisms of BDNF on cognitive functions in drug-naive first episode patients with schizophrenia

Genotype-expression interactions for BDNF across human brain regions

NRN1 genetic variability and methylation changes as biomarkers for cognitive remediation therapy response in schizophrenia

Cell biology of BDNF and its relevance to schizophrenia.

Relationship Between Brain-Derived Neurotrophic Factor Gene C270T Polymorphisms and the Psychotic Symptoms and Cognitive Functioning of Patients with Schizophrenia.

The interaction of RELN–DNMT genes involving in neurotrophin signaling pathway contributes to schizophrenia susceptibility

Interaction between BDNF and TNF-α genes in schizophrenia.

Brain-derived Neurotrophic Factor and Risk of Schizophrenia: an Association Study and Meta-Analysis

The Interaction of BDNF and NTRK2 Gene Increases the Susceptibility of Paranoid Schizophrenia

NRXN1 is Associated with Enlargement of the Temporal Horns of the Lateral Ventricles in Psychosis

Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample.

Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression

The Effects of a Genome-Wide Supported Variant in the CACNA1C Gene on Cortical Morphology in Schizophrenia Patients and Healthy Subjects

Association of DTNBP1 with Schizophrenia: Findings from Two Independent Samples of Han Chinese Population

Bdnf Gene is A Genetic Risk Factor for Schizophrenia and is Related to the Chlorpromazine-Induced Extrapyramidal Syndrome in the Chinese Population

628. Polygenic Risk Score for Schizophrenia of CREB1 and BDNF Associated with Structural Brain Dysconnectivity